Home » Stocks » Teleflex

Teleflex Incorporated (TFX)

Stock Price: $373.10 USD -12.07 (-3.13%)
Updated Jul 31, 2020 4:03 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 17.36B
Revenue (ttm) 2.53B
Net Income (ttm) 479.80M
Shares Out 46.43M
EPS (ttm) 10.16
PE Ratio 36.72
Forward PE 37.74
Dividend $1.36
Dividend Yield 0.36%

Stock Quote

Trading Day Jul 31, 2020
Last Price $373.10
Previous Close $385.17
Change ($) -12.07
Change (%) -3.13%
Day's Open 383.29
Day's Range 367.37 - 384.33
Day's Volume 307,815
52-Week Range 221.27 - 405.07

More Stats

Market Cap 17.36B
Enterprise Value 19.31B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date May 14, 2020
Shares Outstanding 46.43M
Float 46.37M
EPS (basic) 10.37
EPS (diluted) 10.16
FCF / Share 7.04
Dividend $1.36
Dividend Yield 0.36%
Earnings Yield 2.72%
FCF Yield 1.88%
Payout Ratio 13.10%
Shares Short 669,850
Short Ratio 3.00
Short % of Float 1.87%
Beta 1.00
PE Ratio 36.72
Forward PE 37.74
P/FCF Ratio 53.12
PS Ratio 6.87
PB Ratio 5.82
Revenue 2.53B
Operating Income 440.45M
Net Income 479.80M
Free Cash Flow 326.72M
Net Cash -1.95B
Net Cash / Share -41.92
Gross Margin 59.03%
Operating Margin 17.43%
Profit Margin 19.00%
FCF Margin 12.93%
ROA 4.40%
ROE 16.64%
ROIC 12.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (13)

Buy 11
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$417.73*
(11.96% upside)
Low
334
Current: $373.10
High
450
Target: 417.73
*Average 12-month price target from 11 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue2,5952,4482,1461,8681,8101,8401,6961,5511,4931,398
Revenue Growth6%14.07%14.9%3.22%-1.64%8.46%9.37%3.92%6.78%-
Gross Profit1,4921,3841,172996944942839748709679
Operating Income427322372319316285233-97.38230230
Net Income461201153237245188151-190323201
Shares Outstanding46.2045.6945.0043.3341.5641.3741.1140.8640.5039.91
Earnings Per Share9.804.293.274.985.104.043.45-4.657.924.99
EPS Growth128.44%31.19%-34.34%-2.35%26.24%17.1%--58.72%-
Dividend Per Share1.361.361.701.361.361.361.361.361.361.36
Dividend Growth0%-20%25%0%0%0%0%0%0%-
Operating Cash Flow44043742040830128722818794.48213
Capital Expenditures-103-80.80-70.90-53.14-61.45-67.57-63.58-65.39-44.58-29.33
Free Cash Flow33735734935523921916412149.90184
Cash & Equivalents301357334544338303432337584208
Total Debt2,0102,1592,2501,0331,0591,0681,286970960917
Net Cash / Debt-1,709-1,802-1,916-490-721-765-854-633-376-709
Assets6,3106,2786,1813,8913,8723,9234,2093,7343,9243,643
Liabilities3,3313,7383,7511,7521,8612,0092,2931,9521,9411,856
Book Value2,9792,5402,4312,1382,0091,9111,9141,7791,9811,783
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Teleflex Incorporated
Country United States
Employees 14,400
CEO Liam J. Kelly

Stock Information

Ticker Symbol TFX
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: TFX

Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.